{"id":33984,"date":"2020-08-28T18:23:01","date_gmt":"2020-08-28T17:23:01","guid":{"rendered":"https:\/\/www.biotechpharmasummit.com\/?page_id=33984"},"modified":"2023-05-09T21:51:14","modified_gmt":"2023-05-09T20:51:14","slug":"fabrice-magnino","status":"publish","type":"page","link":"https:\/\/www.biotechpharmasummit.com\/index.php\/liquid-biopsy-2020-speakers\/fabrice-magnino\/","title":{"rendered":"Fabrice Magnino"},"content":{"rendered":"<div class=\"vgblk-rw-wrapper limit-wrapper\">\n\n\t<h2>Fabrice Magnino<\/h2>\n<h4>Assoc Director, Medical Affairs EMEA at illumina<\/h4>\n\tFabrice Magnino is holding a PhD in Tumour Biology from the Medical Faculty of Berne (Switzerland) and received Breast Cancer postdoctoral training at the Cancer Institute of Montpellier (France) before joining the Life Science and Molecular Diagnostic industry where he is focusing on solutions to improve patient management.<br \/>\nFabrice joined Illumina in 2017 to support their precision medicine efforts and the utilisation of new biomarkers in Immuno-Oncology. Within his role Fabrice works closely with experts in the field to generate evidences supporting the value of Next Generation Sequencing for patient stratification and disease progression monitoring.\n\t\t\t\t\t\t\t<img decoding=\"async\" loading=\"lazy\" src=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Fabrice_Magnino_Illumina_Liquid_Biopsy_Lisbon_1.png\" alt=\"Fabrice_Magnino_Illumina_Liquid_Biopsy_Lisbon_1\" itemprop=\"image\" height=\"1224\" width=\"820\" title=\"Fabrice_Magnino_Illumina_Liquid_Biopsy_Lisbon_1\" onerror=\"this.style.display='none'\"  sizes=\"auto, (max-width: 768px) 100vw, 100vw\" srcset=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Fabrice_Magnino_Illumina_Liquid_Biopsy_Lisbon_1.png 820w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Fabrice_Magnino_Illumina_Liquid_Biopsy_Lisbon_1-201x300.png 201w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Fabrice_Magnino_Illumina_Liquid_Biopsy_Lisbon_1-686x1024.png 686w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Fabrice_Magnino_Illumina_Liquid_Biopsy_Lisbon_1-768x1146.png 768w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Fabrice_Magnino_Illumina_Liquid_Biopsy_Lisbon_1-630x940.png 630w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Fabrice_Magnino_Illumina_Liquid_Biopsy_Lisbon_1-420x627.png 420w\" \/>\t\t\t\t\t\t\t\n<h3>\n\tTitle: Liquid Biopsy and Tumour Comprehensive Genomic Profiling &#8211; Future Standard of Care?\n\t<\/h3>\n<ul>\n<li>New paradigm in cancer managment &#8211; One test, multiple drugs, many types of cancer<\/li>\n<li>ctDNA &#8211; From complex to simple<\/li>\n<li>The time is now &#8211; Decentralised precision testing for the beneficts of patients<\/li>\n<li>The Pharma _ CRO _ In-Vitro Diagnostic triangle &#8211; The engine of precision medicine<\/li>\n<\/ul>\n\t<a href=\"https:\/\/sociopharma.com\/\" target=\"_blank\" role=\"button\" rel=\"noopener\">\n\t\t\t\t\tPresentation available only at SocioPharma.com\n\t<\/a>\n<h4>\n\t\t\t<a href=\"#\" title=\"On the Web\" target=\"_self\" rel=\"noopener\">\n\tOn the Web\n\t\t\t<\/a>\n\t<\/h4>\n\t<p><a href=\"https:\/\/www.illumina.com\/\" target=\"_blank\" rel=\"noopener\">https:\/\/www.illumina.com\/<\/a><\/p>\n<h4>\n\t\t\t<a href=\"#\" title=\"On LinkedIn\" target=\"_self\" rel=\"noopener\">\n\tOn LinkedIn\n\t\t\t<\/a>\n\t<\/h4>\n\t<p><a href=\"https:\/\/www.linkedin.com\/in\/fabricemagnino\/\" target=\"_blank\" rel=\"noopener\">Visit profile<\/a><\/p>\n\n<\/div><!-- .vgblk-rw-wrapper -->","protected":false},"excerpt":{"rendered":"<p>Fabrice Magnino Assoc Director, Medical Affairs EMEA at illumina Fabrice Magnino is holding a PhD in Tumour Biology from the Medical Faculty of Berne (Switzerland) and received Breast Cancer postdoctoral training at the Cancer Institute of Montpellier (France) before joining the Life Science and Molecular Diagnostic industry where he is focusing on solutions to improve&#8230;<\/p>\n","protected":false},"author":1,"featured_media":33985,"parent":33918,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"inline_featured_image":false,"footnotes":""},"class_list":["post-33984","page","type-page","status-publish","has-post-thumbnail","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.2 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Fabrice Magnino &#8226; BioTech Pharma Summit<\/title>\n<meta name=\"description\" content=\"Fabrice Magnino is holding a PhD in Tumour Biology from the Medical Faculty of Berne (Switzerland) and received Breast Cancer postdoctoral training at the Cancer Institute of Montpellier\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.biotechpharmasummit.com\/index.php\/liquid-biopsy-2020-speakers\/fabrice-magnino\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Fabrice Magnino &#8226; BioTech Pharma Summit\" \/>\n<meta property=\"og:description\" content=\"Fabrice Magnino is holding a PhD in Tumour Biology from the Medical Faculty of Berne (Switzerland) and received Breast Cancer postdoctoral training at the Cancer Institute of Montpellier\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.biotechpharmasummit.com\/index.php\/liquid-biopsy-2020-speakers\/fabrice-magnino\/\" \/>\n<meta property=\"og:site_name\" content=\"BioTech Pharma Summit\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/biotechpharmasummit\/\" \/>\n<meta property=\"article:modified_time\" content=\"2023-05-09T20:51:14+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Fabrice_Magnino_Illumina_Liquid_Biopsy_Lisbon.png\" \/>\n\t<meta property=\"og:image:width\" content=\"900\" \/>\n\t<meta property=\"og:image:height\" content=\"900\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@biotechsummit\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/liquid-biopsy-2020-speakers\/fabrice-magnino\/\",\"url\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/liquid-biopsy-2020-speakers\/fabrice-magnino\/\",\"name\":\"Fabrice Magnino &#8226; BioTech Pharma Summit\",\"isPartOf\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/liquid-biopsy-2020-speakers\/fabrice-magnino\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/liquid-biopsy-2020-speakers\/fabrice-magnino\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Fabrice_Magnino_Illumina_Liquid_Biopsy_Lisbon.png\",\"datePublished\":\"2020-08-28T17:23:01+00:00\",\"dateModified\":\"2023-05-09T20:51:14+00:00\",\"description\":\"Fabrice Magnino is holding a PhD in Tumour Biology from the Medical Faculty of Berne (Switzerland) and received Breast Cancer postdoctoral training at the Cancer Institute of Montpellier\",\"breadcrumb\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/liquid-biopsy-2020-speakers\/fabrice-magnino\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.biotechpharmasummit.com\/index.php\/liquid-biopsy-2020-speakers\/fabrice-magnino\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/liquid-biopsy-2020-speakers\/fabrice-magnino\/#primaryimage\",\"url\":\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Fabrice_Magnino_Illumina_Liquid_Biopsy_Lisbon.png\",\"contentUrl\":\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Fabrice_Magnino_Illumina_Liquid_Biopsy_Lisbon.png\",\"width\":900,\"height\":900},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/liquid-biopsy-2020-speakers\/fabrice-magnino\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.biotechpharmasummit.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Liquid Biopsy 2020 Speakers\",\"item\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/liquid-biopsy-2020-speakers\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Fabrice Magnino\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#website\",\"url\":\"https:\/\/www.biotechpharmasummit.com\/\",\"name\":\"BioTech Pharma Summit\",\"description\":\"The Tomorrow&#039;s healthcare congress\",\"publisher\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.biotechpharmasummit.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#organization\",\"name\":\"EPM Group\",\"url\":\"https:\/\/www.biotechpharmasummit.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/05\/B_2_Logo_BioTech_Pharma_Summit_Porto.png\",\"contentUrl\":\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/05\/B_2_Logo_BioTech_Pharma_Summit_Porto.png\",\"width\":2000,\"height\":2000,\"caption\":\"EPM Group\"},\"image\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/biotechpharmasummit\/\",\"https:\/\/x.com\/biotechsummit\",\"https:\/\/www.instagram.com\/biotechpharmasummit\/\",\"https:\/\/www.linkedin.com\/company\/biotech-pharma-summit\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Fabrice Magnino &#8226; BioTech Pharma Summit","description":"Fabrice Magnino is holding a PhD in Tumour Biology from the Medical Faculty of Berne (Switzerland) and received Breast Cancer postdoctoral training at the Cancer Institute of Montpellier","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.biotechpharmasummit.com\/index.php\/liquid-biopsy-2020-speakers\/fabrice-magnino\/","og_locale":"en_US","og_type":"article","og_title":"Fabrice Magnino &#8226; BioTech Pharma Summit","og_description":"Fabrice Magnino is holding a PhD in Tumour Biology from the Medical Faculty of Berne (Switzerland) and received Breast Cancer postdoctoral training at the Cancer Institute of Montpellier","og_url":"https:\/\/www.biotechpharmasummit.com\/index.php\/liquid-biopsy-2020-speakers\/fabrice-magnino\/","og_site_name":"BioTech Pharma Summit","article_publisher":"https:\/\/www.facebook.com\/biotechpharmasummit\/","article_modified_time":"2023-05-09T20:51:14+00:00","og_image":[{"width":900,"height":900,"url":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Fabrice_Magnino_Illumina_Liquid_Biopsy_Lisbon.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_site":"@biotechsummit","twitter_misc":{"Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/liquid-biopsy-2020-speakers\/fabrice-magnino\/","url":"https:\/\/www.biotechpharmasummit.com\/index.php\/liquid-biopsy-2020-speakers\/fabrice-magnino\/","name":"Fabrice Magnino &#8226; BioTech Pharma Summit","isPartOf":{"@id":"https:\/\/www.biotechpharmasummit.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/liquid-biopsy-2020-speakers\/fabrice-magnino\/#primaryimage"},"image":{"@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/liquid-biopsy-2020-speakers\/fabrice-magnino\/#primaryimage"},"thumbnailUrl":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Fabrice_Magnino_Illumina_Liquid_Biopsy_Lisbon.png","datePublished":"2020-08-28T17:23:01+00:00","dateModified":"2023-05-09T20:51:14+00:00","description":"Fabrice Magnino is holding a PhD in Tumour Biology from the Medical Faculty of Berne (Switzerland) and received Breast Cancer postdoctoral training at the Cancer Institute of Montpellier","breadcrumb":{"@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/liquid-biopsy-2020-speakers\/fabrice-magnino\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.biotechpharmasummit.com\/index.php\/liquid-biopsy-2020-speakers\/fabrice-magnino\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/liquid-biopsy-2020-speakers\/fabrice-magnino\/#primaryimage","url":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Fabrice_Magnino_Illumina_Liquid_Biopsy_Lisbon.png","contentUrl":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Fabrice_Magnino_Illumina_Liquid_Biopsy_Lisbon.png","width":900,"height":900},{"@type":"BreadcrumbList","@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/liquid-biopsy-2020-speakers\/fabrice-magnino\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.biotechpharmasummit.com\/"},{"@type":"ListItem","position":2,"name":"Liquid Biopsy 2020 Speakers","item":"https:\/\/www.biotechpharmasummit.com\/index.php\/liquid-biopsy-2020-speakers\/"},{"@type":"ListItem","position":3,"name":"Fabrice Magnino"}]},{"@type":"WebSite","@id":"https:\/\/www.biotechpharmasummit.com\/#website","url":"https:\/\/www.biotechpharmasummit.com\/","name":"BioTech Pharma Summit","description":"The Tomorrow&#039;s healthcare congress","publisher":{"@id":"https:\/\/www.biotechpharmasummit.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.biotechpharmasummit.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.biotechpharmasummit.com\/#organization","name":"EPM Group","url":"https:\/\/www.biotechpharmasummit.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.biotechpharmasummit.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/05\/B_2_Logo_BioTech_Pharma_Summit_Porto.png","contentUrl":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/05\/B_2_Logo_BioTech_Pharma_Summit_Porto.png","width":2000,"height":2000,"caption":"EPM Group"},"image":{"@id":"https:\/\/www.biotechpharmasummit.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/biotechpharmasummit\/","https:\/\/x.com\/biotechsummit","https:\/\/www.instagram.com\/biotechpharmasummit\/","https:\/\/www.linkedin.com\/company\/biotech-pharma-summit\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/pages\/33984","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/comments?post=33984"}],"version-history":[{"count":6,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/pages\/33984\/revisions"}],"predecessor-version":[{"id":38340,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/pages\/33984\/revisions\/38340"}],"up":[{"embeddable":true,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/pages\/33918"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/media\/33985"}],"wp:attachment":[{"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/media?parent=33984"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}